Galapagos - 48 Year Dividend History | GLPG

Historical dividend payout and yield for Galapagos (GLPG) since 1971. The current TTM dividend payout for Galapagos (GLPG) as of June 14, 2019 is $0.00. The current dividend yield for Galapagos as of June 14, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $6.209B $0.376B
Galapagos NV is a biotechnology company. The Company's operating segment consists of Research and Development and Services. Research and Development segment is engaged in the discovery and development of small molecules. Services segment offers drug discovery products and services. Its products include GLPG0634 for the treatment of rheumatoid arthritis and other inflammatory diseases, GLPG1205/GLPG1690 for treating inflammatory bowel disease, GSK2586184 for the treatment of chronic immuno-inflammatory diseases and GLPG0974, to prevent free fatty acid-induced activation and migration of neutrophils which are in different clinical trial. Galapagos NV is headquartered in Mechelen, Belgium.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $107.397B 12.14
Gilead Sciences (GILD) United States $84.602B 10.27
Bio-Techne Corp (TECH) United States $7.890B 53.83